Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers
Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screenin...
Gespeichert in:
| Veröffentlicht in: | Trends in cardiovascular medicine Jg. 27; H. 2; S. 123 - 133 |
|---|---|
| Hauptverfasser: | , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Elsevier Inc
01.02.2017
Elsevier Limited |
| Schlagworte: | |
| ISSN: | 1050-1738, 1873-2615, 1873-2615 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related to CVD over the past 30 years have led to more sensitive screening methods, a greater emphasis on its early detection and diagnosis, and improved treatments resulting in more favorable clinical outcomes in the community. However, the use of biomarkers for different purposes in CVD remains an important area of research that has been explored by scientists over the years and many new developments are still underway. Therefore, a detailed description of all CVD biomarkers that are currently been used or investigated for future use in the field of cardiovascular medicine is out of scope for any review article. In the present review, we do not intend to replicate the information from previous exhaustive review on biomarkers, but highlight key statistical and clinical issues with an emphasis on methods to evaluate the incremental yield of biomarkers, including their clinical utility, a prerequisite before any putative novel biomarker is utilized in clinical practice. In addition, we will summarize information regarding recent novel heart failure biomarkers in current practice, which are undergoing scrutiny before they can be available for clinical use, and their impact on clinical outcomes. |
|---|---|
| AbstractList | Abstract Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related to CVD over the past 30 years have led to more sensitive screening methods, a greater emphasis on its early detection and diagnosis, and improved treatments resulting in more favorable clinical outcomes in the community. However, the use of biomarkers for different purposes in CVD remains an important area of research that has been explored by scientists over the years and many new developments are still underway. Therefore, a detailed description of all CVD biomarkers that are currently been used or investigated for future use in the field of cardiovascular medicine is out of scope for any review article. In the present review, we do not intend to replicate the information from previous exhaustive review on biomarkers, but highlight key statistical and clinical issues with an emphasis on methods to evaluate the incremental yield of biomarkers, including their clinical utility, a prerequisite before any putative novel biomarker is utilized in clinical practice. In addition, we will summarize information regarding recent novel heart failure biomarkers in current practice, which are undergoing scrutiny before they can be available for clinical use, and their impact on clinical outcomes. Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related to CVD over the past 30 years have led to more sensitive screening methods, a greater emphasis on its early detection and diagnosis, and improved treatments resulting in more favorable clinical outcomes in the community. However, the use of biomarkers for different purposes in CVD remains an important area of research that has been explored by scientists over the years and many new developments are still underway. Therefore, a detailed description of all CVD biomarkers that are currently been used or investigated for future use in the field of cardiovascular medicine is out of scope for any review article. In the present review, we do not intend to replicate the information from previous exhaustive review on biomarkers, but highlight key statistical and clinical issues with an emphasis on methods to evaluate the incremental yield of biomarkers, including their clinical utility, a prerequisite before any putative novel biomarker is utilized in clinical practice. In addition, we will summarize information regarding recent novel heart failure biomarkers in current practice, which are undergoing scrutiny before they can be available for clinical use, and their impact on clinical outcomes. Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related to CVD over the past 30 years have led to more sensitive screening methods, a greater emphasis on its early detection and diagnosis, and improved treatments resulting in more favorable clinical outcomes in the community. However, the use of biomarkers for different purposes in CVD remains an important area of research that has been explored by scientists over the years and many new developments are still underway. Therefore, a detailed description of all CVD biomarkers that are currently been used or investigated for future use in the field of cardiovascular medicine is out of scope for any review article. In the present review, we do not intend to replicate the information from previous exhaustive review on biomarkers, but highlight key statistical and clinical issues with an emphasis on methods to evaluate the incremental yield of biomarkers, including their clinical utility, a prerequisite before any putative novel biomarker is utilized in clinical practice. In addition, we will summarize information regarding recent novel heart failure biomarkers in current practice, which are undergoing scrutiny before they can be available for clinical use, and their impact on clinical outcomes.Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related to CVD over the past 30 years have led to more sensitive screening methods, a greater emphasis on its early detection and diagnosis, and improved treatments resulting in more favorable clinical outcomes in the community. However, the use of biomarkers for different purposes in CVD remains an important area of research that has been explored by scientists over the years and many new developments are still underway. Therefore, a detailed description of all CVD biomarkers that are currently been used or investigated for future use in the field of cardiovascular medicine is out of scope for any review article. In the present review, we do not intend to replicate the information from previous exhaustive review on biomarkers, but highlight key statistical and clinical issues with an emphasis on methods to evaluate the incremental yield of biomarkers, including their clinical utility, a prerequisite before any putative novel biomarker is utilized in clinical practice. In addition, we will summarize information regarding recent novel heart failure biomarkers in current practice, which are undergoing scrutiny before they can be available for clinical use, and their impact on clinical outcomes. |
| Author | Vasan, Ramachandran S. Dhingra, Ravi |
| Author_xml | – sequence: 1 givenname: Ravi surname: Dhingra fullname: Dhingra, Ravi email: Rdhingra@medicine.wisc.edu, ravidhingra27@hotmail.com – sequence: 2 givenname: Ramachandran S. surname: Vasan fullname: Vasan, Ramachandran S. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27576060$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUl1rFDEUHaRiP_QH-CIBX3zZ9WYy-RiFQi22CgUfqs8hk9yx2c4mNZlZ6L83w7ZVF6xCIBdyzrnn5p7Dai_EgFX1ksKSAhVvV8vRrpd1KZcglwD8SXVAlWSLWlC-V2rgsKCSqf3qMOcVAIhG0GfVfi25FCDgoAoffFybdI0pEx-INcn5uDHZToNJxPmMJuM7cjma0efRWzMQkzPmvMYwEhMcyWhHHwMp5xpvSYgbHMgVmjSS3vhhSki6hx7Pq6e9GTK-uLuPqm9nH7-eflpcfDn_fHpysbCSs3EhJesaBk3dqqapO8XQubaW2ItGOWiFaDvXMWOwbZWoTd-hUb3tgDusG1PYR9XxVvdm6tbobDGbzKBvki9GbnU0Xv_5EvyV_h43mtecgWqKwJs7gRR_TJhHvfbZ4jCYgHHKmiqhGFMA_wPlrWSt5KpAX-9AV3FKofzELEhpI1vBC-rV7-YfXN9vrQDkFmBTzDlhr62fFxTnWfygKeg5H3qlSz70nA8NUpd8FCbdYd6LP8Z5v-VgWdjGY9LZegwWnU9l99pF_yj7eIdtBx_mIJW0YP41v861Bn05Z3aOLBUM5roItH8X-EfznwQZ_I0 |
| CitedBy_id | crossref_primary_10_1016_j_envres_2024_119846 crossref_primary_10_1021_acs_jproteome_5c00221 crossref_primary_10_3389_fendo_2024_1458196 crossref_primary_10_1038_s41598_020_71531_8 crossref_primary_10_1155_2021_6830560 crossref_primary_10_1093_cvr_cvaa272 crossref_primary_10_1097_MOL_0000000000000906 crossref_primary_10_1016_j_numecd_2025_103899 crossref_primary_10_1093_aje_kwae312 crossref_primary_10_3389_fphar_2023_1298172 crossref_primary_10_3390_jcm14030887 crossref_primary_10_1038_s41598_021_85991_z crossref_primary_10_3390_chemosensors13070248 crossref_primary_10_7759_cureus_51874 crossref_primary_10_3390_biomedicines11071907 crossref_primary_10_2174_0929867330666230306143351 crossref_primary_10_1080_23737484_2023_2194249 crossref_primary_10_1016_j_electacta_2024_144726 crossref_primary_10_1053_j_jvca_2019_10_014 crossref_primary_10_1155_2021_3090120 crossref_primary_10_1186_s13040_020_00217_8 crossref_primary_10_3389_fcvm_2022_835138 crossref_primary_10_3390_cells10030629 crossref_primary_10_1371_journal_pone_0312072 crossref_primary_10_1111_dom_16469 crossref_primary_10_1186_s13287_019_1451_2 crossref_primary_10_1136_bmjopen_2021_058042 crossref_primary_10_1016_j_lfs_2024_122484 crossref_primary_10_1016_j_carpath_2019_107150 crossref_primary_10_1002_adhm_202500122 crossref_primary_10_1161_ATVBAHA_120_315793 crossref_primary_10_1016_j_jhazmat_2025_138240 crossref_primary_10_1016_j_atherosclerosis_2024_118584 crossref_primary_10_1089_rej_2018_2094 crossref_primary_10_52711_2231_5691_2022_00038 crossref_primary_10_1080_08839514_2022_2031816 crossref_primary_10_3390_biomedicines10010162 crossref_primary_10_1161_JAHA_123_030131 crossref_primary_10_1016_j_cegh_2021_100937 crossref_primary_10_3389_fphys_2023_1034170 crossref_primary_10_1080_00015385_2024_2410599 crossref_primary_10_3389_fcvm_2020_579567 crossref_primary_10_3390_biom14121630 crossref_primary_10_1007_s11524_020_00499_7 crossref_primary_10_1016_j_repc_2022_01_009 crossref_primary_10_1093_rheumatology_keab277 crossref_primary_10_1007_s40200_021_00842_y crossref_primary_10_3390_genes11020164 crossref_primary_10_1016_j_jalz_2017_01_008 crossref_primary_10_1016_j_abb_2018_11_021 crossref_primary_10_3390_ijms232416139 crossref_primary_10_1016_j_bios_2021_113617 crossref_primary_10_1002_ehf2_13239 crossref_primary_10_1093_nutrit_nuab104 crossref_primary_10_1016_j_bios_2020_112065 crossref_primary_10_1016_j_microc_2020_104857 crossref_primary_10_1038_s41598_024_81876_z crossref_primary_10_2147_JBM_S457371 crossref_primary_10_1016_j_talanta_2025_128362 crossref_primary_10_3390_nu17010042 crossref_primary_10_1097_CRD_0000000000000500 crossref_primary_10_3390_app14135890 crossref_primary_10_3389_fcvm_2021_754499 crossref_primary_10_1038_s41598_023_30231_9 crossref_primary_10_1016_j_actatropica_2022_106705 crossref_primary_10_7759_cureus_39395 crossref_primary_10_2217_bmm_2019_0185 crossref_primary_10_1038_s41598_021_00760_2 crossref_primary_10_1016_j_preghy_2017_10_012 crossref_primary_10_3390_s19225003 crossref_primary_10_1007_s11695_024_07258_6 crossref_primary_10_3390_children9050740 crossref_primary_10_3390_s22145200 crossref_primary_10_3389_fpubh_2023_1280185 crossref_primary_10_1016_j_cotox_2019_11_001 crossref_primary_10_1002_jcp_28393 crossref_primary_10_1097_MD_0000000000033953 crossref_primary_10_3390_diagnostics11010145 crossref_primary_10_1186_s12959_021_00354_y crossref_primary_10_1016_j_trac_2022_116896 crossref_primary_10_1038_s41598_023_38102_z crossref_primary_10_1007_s11033_024_10077_8 crossref_primary_10_1038_s41598_024_61077_4 crossref_primary_10_1016_j_jaim_2024_100975 crossref_primary_10_3390_bios13020282 crossref_primary_10_1002_clc_24315 crossref_primary_10_1042_BSR20210326 crossref_primary_10_2217_bmm_2018_0056 crossref_primary_10_1016_j_snb_2021_131180 crossref_primary_10_1016_j_ijcchd_2024_100522 crossref_primary_10_1186_s12986_023_00754_z crossref_primary_10_3389_fimmu_2022_861665 crossref_primary_10_3390_bios14090441 crossref_primary_10_1155_2018_3406028 crossref_primary_10_1002_bkcs_12434 crossref_primary_10_1016_j_heliyon_2023_e23682 crossref_primary_10_1210_clinem_dgab538 crossref_primary_10_2147_JPR_S472934 crossref_primary_10_1161_CIRCRESAHA_125_325515 crossref_primary_10_1109_JSEN_2021_3072578 crossref_primary_10_1038_s41366_021_00906_2 crossref_primary_10_1016_j_ctim_2025_103135 crossref_primary_10_2174_138161282601200225102449 crossref_primary_10_1016_j_critrevonc_2018_02_002 crossref_primary_10_1055_a_1970_7892 crossref_primary_10_3389_fcvm_2021_728198 crossref_primary_10_1016_j_elecom_2025_107968 crossref_primary_10_1016_j_nexres_2025_100418 crossref_primary_10_1186_s12916_019_1368_8 crossref_primary_10_1016_j_ijbiomac_2024_138115 crossref_primary_10_2174_011573403X340118241113025519 crossref_primary_10_3390_vetsci12030289 crossref_primary_10_1016_j_microc_2019_104334 crossref_primary_10_1007_s00216_019_02199_x crossref_primary_10_1007_s12551_022_00990_2 crossref_primary_10_1016_j_heliyon_2024_e35447 crossref_primary_10_1002_hsr2_70878 |
| Cites_doi | 10.1093/oxfordjournals.aje.a113284 10.1073/pnas.0805038105 10.1016/j.cardfail.2008.07.231 10.1148/radiology.143.1.7063747 10.1016/j.jprot.2014.10.017 10.1002/sim.4085 10.1161/CIRCHEARTFAILURE.108.833707 10.1161/01.RES.86.9.939 10.1073/pnas.100127897 10.1016/0735-1097(95)00338-X 10.1007/s11897-013-0160-x 10.1007/s00441-004-0986-3 10.1038/nrcardio.2015.105 10.1161/CIRCULATIONAHA.114.010696 10.1161/CIRCULATIONAHA.108.821769 10.1161/CIRCULATIONAHA.107.727545 10.1016/j.jacc.2010.02.025 10.1001/jama.2010.1708 10.1161/CIRCULATIONAHA.114.013220 10.1016/j.jacc.2007.04.091 10.1093/clinchem/38.5.648 10.1161/CIRCULATIONAHA.104.482570 10.1038/ng.327 10.1093/eurjhf/hfr087 10.1056/NEJMoa1409077 10.1038/jhg.2015.78 10.1093/jnci/95.7.511 10.1161/CIRCHEARTFAILURE.110.960096 10.1016/j.jacc.2006.03.061 10.1161/01.CIR.0000127958.21003.5A 10.1002/ejhf.332 10.1093/eurjhf/hfq091 10.1038/ng.3396 10.1161/01.cir.0000437913.98912.1d 10.1016/j.jchf.2014.02.005 10.1038/nrg2521 10.1016/j.jacc.2007.02.037 10.1161/CIRCULATIONAHA.106.672402 10.1126/science.8091226 10.1136/adc.83.6.459 10.1038/nm1582 10.1038/nrg1379 10.1016/j.amjcard.2011.05.033 10.1016/j.jacc.2008.03.050 10.1161/01.CIR.92.3.286 10.1056/NEJMra0800239 10.1111/eci.12234 10.1111/j.0006-341X.2000.00352.x 10.1152/physiolgenomics.00255.2004 10.1161/CIRCULATIONAHA.110.005264 10.1161/01.CIR.0000148178.19465.11 10.1016/j.yjmcc.2015.10.028 10.1161/01.cir.0000437741.48606.98 10.1093/eurjhf/hfq210 10.1097/EDE.0b013e3181c30fb2 10.1002/jcb.24307 10.1016/j.jprot.2011.04.027 10.1172/JCI30634 10.1161/CIRCGENETICS.108.806935 10.1161/CIRCULATIONAHA.110.979740 10.1161/CIRCULATIONAHA.107.187397 10.1373/clinchem.2006.076828 10.1093/eurheartj/ehr032 10.1038/nrclinonc.2011.121 10.1093/clinchem/21.13.1873 10.1002/ejhf.495 10.1172/JCI118680 10.1161/01.RES.0000202804.84885.d0 10.1093/eurjhf/hfr047 10.1161/CIRCULATIONAHA.105.583815 10.1053/jhep.2001.22172 10.1093/cvr/cvr344 10.1161/ATVBAHA.114.305176 10.1002/ejhf.244 10.1056/NEJMp1500523 10.1161/CIRCULATIONAHA.107.687947 10.1161/CIRCULATIONAHA.107.728022 10.1161/CIRCULATIONAHA.110.991943 10.1200/JCO.2004.01.0454 10.1373/49.1.1 10.1002/sim.2929 10.1056/NEJMoa072366 10.7326/0003-4819-150-2-200901200-00003 10.1161/JAHA.114.000923 10.1161/CIRCGENETICS.108.815605 10.1056/NEJMoa0706824 10.1016/j.jacc.2008.01.041 10.1016/j.cardfail.2011.02.003 10.1161/CIRCHEARTFAILURE.112.972653 10.3109/07853890.2010.538080 10.1161/CIRCULATIONAHA.106.685503 10.1158/1078-0432.CCR-12-3722 10.1073/pnas.1401724111 10.1056/NEJMoa055373 10.1016/j.atherosclerosis.2011.11.038 10.1161/01.CIR.0000033117.39335.DF 10.1038/nature07511 10.1373/clinchem.2008.117218 10.1016/j.jacc.2004.06.076 10.1177/2047487313487083 10.1161/CIRCULATIONAHA.109.912568 10.1161/01.RES.0000201280.20709.26 10.1111/j.1365-2796.2011.02503.x 10.1001/jama.286.2.180 10.1016/j.jacc.2011.07.032 10.1136/bmj.329.7458.168 10.1056/NEJMp0808934 10.1161/01.CIR.102.25.3046 10.1056/NEJMoa0912965 10.1161/CIR.0b013e31821c7c64 10.1056/NEJMoa1107477 10.1161/CIRCULATIONAHA.111.044149 10.1017/S0007114514002657 10.1161/CIRCRESAHA.114.303915 10.1161/01.CIR.0000084543.79097.34 10.1177/2047487314552797 10.1161/CIRCHEARTFAILURE.113.000266 10.1161/CIRCULATIONAHA.109.192278 10.1016/S0021-9258(18)82217-7 10.1016/j.jacc.2007.05.014 10.1067/mcp.2001.113989 10.1152/physiolgenomics.00122.2001 10.1056/NEJMra0808700 10.1056/NEJMp068249 10.1136/bmjopen-2013-004188 10.1111/j.2517-6161.1972.tb00899.x |
| ContentType | Journal Article |
| Copyright | 2016 Elsevier Inc. Elsevier Inc. Copyright © 2016 Elsevier Inc. All rights reserved. Copyright Elsevier Limited 2017 |
| Copyright_xml | – notice: 2016 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2016 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited 2017 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. NAPCQ 7X8 5PM |
| DOI | 10.1016/j.tcm.2016.07.005 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Nursing and Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-2615 |
| EndPage | 133 |
| ExternalDocumentID | PMC5253084 4307170091 27576060 10_1016_j_tcm_2016_07_005 S1050173816301050 1_s2_0_S1050173816301050 |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: National Health Institute grantid: NO1 25195; HHSN268201500001I – fundername: NHLBI NIH HHS grantid: N01 HC025195 – fundername: NHLBI NIH HHS grantid: HHSN268201500001I – fundername: NHLBI NIH HHS grantid: HHSN268201500001C |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W KOM M29 M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSZ SV3 T5K WOW WUQ Z5R ~G- ~HD 3V. 7RV 7X7 8FI AACTN AFCTW AFKRA AFKWA AJOXV AMFUW AZQEC BENPR FYUFA GUQSH M1P M2O RIG AAIAV ABLVK ABYKQ AJBFU LCYCR 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7TK K9. NAPCQ 7X8 5PM |
| ID | FETCH-LOGICAL-c753t-773b4304298442b83edd927ef648d09669bdb3aae99862afbea8fcb05de24a773 |
| ISICitedReferencesCount | 145 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000393935500007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1050-1738 1873-2615 |
| IngestDate | Tue Sep 30 16:59:42 EDT 2025 Thu Oct 02 20:22:53 EDT 2025 Sat Sep 27 17:08:03 EDT 2025 Tue Oct 07 06:23:22 EDT 2025 Mon Jul 21 06:01:33 EDT 2025 Sat Nov 29 07:46:46 EST 2025 Tue Nov 18 22:11:48 EST 2025 Fri Feb 23 02:27:51 EST 2024 Tue Feb 25 20:00:11 EST 2025 Tue Oct 14 19:28:13 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Heart failure Biomarkers Cardiovascular disease |
| Language | English |
| License | Copyright © 2016 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c753t-773b4304298442b83edd927ef648d09669bdb3aae99862afbea8fcb05de24a773 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://doi.org/10.1016/j.tcm.2016.07.005 |
| PMID | 27576060 |
| PQID | 1861147965 |
| PQPubID | 1216377 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5253084 proquest_miscellaneous_1868338004 proquest_miscellaneous_1859739758 proquest_journals_1861147965 pubmed_primary_27576060 crossref_citationtrail_10_1016_j_tcm_2016_07_005 crossref_primary_10_1016_j_tcm_2016_07_005 elsevier_sciencedirect_doi_10_1016_j_tcm_2016_07_005 elsevier_clinicalkeyesjournals_1_s2_0_S1050173816301050 elsevier_clinicalkey_doi_10_1016_j_tcm_2016_07_005 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-02-01 |
| PublicationDateYYYYMMDD | 2017-02-01 |
| PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Philadelphia |
| PublicationTitle | Trends in cardiovascular medicine |
| PublicationTitleAlternate | Trends Cardiovasc Med |
| PublicationYear | 2017 |
| Publisher | Elsevier Inc Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
| References | Lemeshow, Hosmer (bib25) 1982; 115 Hardy, Singleton (bib56) 2009; 360 Kamath, Wiesner, Malinchoc, Kremers, Therneau, Kosberg (bib32) 2001; 33 Neuhold, Huelsmann, Strunk, Stoiser, Struck, Morgenthaler (bib88) 2008; 52 Napoli, Zullo, Picascia, Infante, Mancini (bib65) 2013; 114 Zolk, Ng, O׳Brien, Weyand, Eschenhagen (bib132) 2002; 106 Wang, Gona, Larson, Tofler, Levy, Newton-Cheh (bib31) 2006; 355 D׳Agostino, Grundy, Sullivan, Wilson (bib23) 2001; 286 Melman, Shah, Danielson, Xiao, Simonson, Barth (bib120) 2015; 131 Masson, Anand, Favero, Barlera, Vago, Bertocchi (bib82) 2012; 125 Braunwald (bib68) 2008; 358 Peacock, De Marco, Fonarow, Diercks, Wynne, Apple (bib83) 2008; 358 Kelly, Squire, Khan, Quinn, Struck, Morgenthaler (bib87) 2008; 14 Ahmad, Fiuzat, Pencina, Geller, Zannad, Cleland (bib71) 2014; 2 Edelmann, Holzendorf, Wachter, Nolte, Schmidt, Kraigher-Krainer (bib97) 2014 [accessed 19.07.16]. Nishikimi, Saito, Kitamura, Ishimitsu, Eto, Kangawa (bib107) 1995; 26 Baker (bib34) 2003; 95 Solberg (bib16) 1987; 25 Hirschhorn (bib53) 2009; 360 Wilson (bib62) 2008; 1 Thygesen, Alpert, White, Allan S.Jaffe (bib4) 2007; 116 McMurray, Packer, Desai, Gong, Lefkowitz, Rizkala (bib73) 2014; 371 Friddle, Koga, Rubin, Bristow (bib44) 2000; 97 Huan, Rong, Tanriverdi, Meng, Bhattacharya, McManus (bib67) 2015; 35 Care, Catalucci, Felicetti, Bonci, Addario, Gallo (bib115) 2007; 13 Hanley, McNeil (bib35) 1982; 143 McShane, Altman, Sauerbrei, Taube, Gion, Clark (bib28) 2005; 23 Shah, Chen-Tournoux, Picard, van Kimmenade, Januzzi (bib104) 2009; 2 Samani, Erdmann, Hall, Hengstenberg, Mangino, Mayer (bib54) 2007; 357 Fox, Musani, Bidulescu, Nagarajarao, Samdarshi, Gebreab (bib75) 2011; 124 Sabatine, Morrow, Higgins, MacGillivray, Guo, Bode (bib102) 2008; 117 Kumarswamy, Bauters, Volkmann, Maury, Fetisch, Holzmann (bib127) 2014; 114 Sanada, Hakuno, Higgins, Schreiter, McKenzie, Lee (bib100) 2007; 117 Xue, Clopton, Peacock, Maisel (bib84) 2011; 13 Nazer, Ray, Sloan, Scirica, Morrow, Cannon (bib131) 2011; 32 Yao, Chen, Joehanes, Otlu, Zhang, Liu (bib66) 2015; 131 Khan, Dhillon, O׳Brien, Struck, Quinn, Morgenthaler (bib85) 2007; 115 Horwich, Patel, MacLellan, Fonarow (bib81) 2003; 108 Paynter, Chasman, Buring, Shiffman, Cook, Ridker (bib57) 2009; 150 Melman, Shah, Das (bib119) 2014; 7 Tijsen, Pinto, Creemers (bib118) 2012; 93 Maisel, Mueller, Nowak, Peacock, Landsberg, Ponikowski (bib77) 2010; 55 Dhingra, Pencina, Schrader, Wang, Levy, Pencina (bib98) 2009; 119 Collins, Varmus (bib10) 2015; 372 Ueland, Jemtland, Godang, Kjekshus, Hognestad, Omland (bib128) 2004; 44 Kittleson, Minhas, Irizarry, Ye, Edness, Breton (bib47) 2005; 21 Stanton, Garrard, Damm, Garrick, Lam, Kapoun (bib46) 2000; 86 Daniels, Maisel (bib70) 2015; 12 Balagopal, de Ferranti, Cook, Daniels, Gidding, Hayman (bib2) 2011; 123 Maisel, Mueller, Fitzgerald, Brikhan, Hiestand, Iqbal (bib90) 2011; 13 Wang (bib8) 2011; 123 Ray, Reddy, Choudhary, Raghu, Srivastava (bib61) 2011; 74 Atkinson, Colburn, DeGruttola, DeMets, Downing, Hoth (bib6) 2001; 69 Bossuyt, Reitsma, Bruns, Gatsonis, Glasziou, Irwig (bib27) 2003; 49 Malottki, Biswas, Deeks, Riley, Craddock, Johnson (bib12) 2014; 4 Watson, Gupta, O׳Connell, Thum, Glezeva, Fendrich (bib125) 2015; 17 de Boer, Lok, Jaarsma, van der Meer, Voors, Hillege (bib95) 2010; 43 Shimpo, Morrow, Weinberg, Sabatine, Murphy, Antman (bib101) 2004; 109 Cook (bib37) 2007; 115 Vasan (bib5) 2006; 113 [accessed 23.07.16]. Pascual-Figal, Manzano-Fernandez, Boronat, Casas, Garrido, Bonaque (bib105) 2011; 13 Tajik, Zwinderman, Mol, Bossuyt (bib13) 2013; 19 Myocardial Infarction Genetic Consortium, Kathiresan, Voight, Purcell, Musunuru, Ardissino (bib55) 2009; 41 Xu, Kimball, Lorenz, Brown, Bauskin, Klevitsky (bib110) 2006; 98 Ware (bib29) 2006; 355 Daniels, Clopton, Laughlin, Maisel, Barrett-Connor (bib113) 2011; 123 Hwang, Allen, Tseng, Lam, Fananapazir, Dzau (bib50) 2002; 10 Ronsein, Pamir, von Haller, Kim, Oda, Jarvik (bib64) 2015; 113 van Rooij, Sutherland, Thatcher, DiMaio, Naseem, Marshall (bib117) 2008; 105 Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, Khan AM, et al. Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol 108:979–984. Kempf, Horn-Wichmann, Brabant, Peter, Allhoff, Klein (bib111) 2007; 53 Khan, Dhillon, Kelly, Squire, Struck, Quinn (bib78) 2008; 51 Schlittenhardt, Schober, Strelau, Bonaterra, Schmiedt, Unsicker (bib109) 2004; 318 Askevold, Nymo, Ueland, Gravning, Wergeland, Kjekshus (bib133) 2013; 6 Jougasaki, Rodeheffer, Redfield, Yamamoto, Wei, McKinley (bib108) 1996; 97 Kempf, von Haehling, Peter, Allhoff, Cicoira, Doehner (bib112) 2007; 50 Maisel (bib69) 2011; 58 deFilippi, de Lemos, Christenson (bib79) 2010; 304 Thum, Galuppo, Wolf, Fiedler, Kneitz, van Laake (bib122) 2007; 116 Pencina, D׳Agostino, D׳Agostino, Vasan (bib38) 2008; 27 Yang, Moravec, Sussman, DiPaola, Fu, Hawthorn (bib48) 2000; 102 Kjeldsen, Johnsen, Sengelov, Borregaard (bib89) 1993; 268 Wade (bib26) 2000; 83 Fonarow, Peacock, Phillips, Givertz, Lopatin (bib72) 2007; 49 Pepe (bib36) 2000; 56 Saunders, Nambi, de Lemos, Chambless, Virani, Boerwinkle (bib80) 2011; 123 Deeks, Altman (bib15) 2004; 329 Bjerre, Pedersen, Mogelvang, Lindberg, Jensen, Galatius (bib129) 2013; 20 Vegter, van der Meer, De Windt, Pinto, Voors (bib123) 2016; 18 Kittleson, Ye, Irizarry, Minhas, Edness, Conte (bib49) 2004; 110 Goff, Lloyd-Jones, Bennett, Coady, D׳Agostino, Gibbons (bib3) 2014; 129 Shah, Chen-Tournoux, Picard, van Kimmenade, Januzzi (bib96) 2010; 12 Jougasaki, Wei, McKinley, Burnett (bib106) 1995; 92 Pencina, D׳Agostino, Steyerberg (bib39) 2011; 30 Akat, Moore-McGriff, Morozov, Brown, Gogakos, Correa Da Rosa (bib124) 2014; 111 Pham, Teuteberg, Kfoury, Starling, Deng, Cappola (bib51) 2010; 362 He, Hannon (bib114) 2004; 5 Mercer, Dinger, Mattick (bib126) 2009; 10 Lander, Schork (bib52) 1994; 265 Tonelli, Sacks, Arnold, Moye, Davis, Pfeffer (bib134) 2008; 117 The CARD (bib59) 2015; 47 O׳Meara, de Denus, Rouleau, Desai (bib99) 2013; 10 Nymo, Ueland, Askevold, Flo, Kjekshus, Hulthe (bib91) 2012; 271 Srivatsan, George, Shanmugam (bib93) 2015; 22 Calore, De Windt, Rampazzo (bib43) 2015; 89 Steyerberg, Vickers, Cook, Gerds, Gonen, Obuchowski (bib40) 2010; 21 Roden (bib42) 2015; 61 van Kimmenade, Januzzi, Ellinor, Sharma, Bakker, Low (bib94) 2006; 48 Hlatky, Greenland, Arnett, Ballantyne, Criqui, Elkind (bib7) 2009; 119 Ovchinnikova, Schmitter, Vegter, ter Maaten, Valente, Liu (bib121) 2016; 18 Sheehy, Huang, Parker (bib45) 2009; 2 Ganesh, Arnett, Assimes, Basson, Chakravarti, Ellinor (bib58) 2013; 128 Zeng, He, Dong, Zhao, Chen, Song (bib21) 2014; 112 McGregor, Dunn (bib60) 2006; 98 Lott, Mitchell, Moeschberger, Sutherland (bib17) 1992; 38 Thum, Gross, Fiedler, Fischer, Kissler, Bussen (bib116) 2008; 456 Shrestha, Borowski, Troughton, Thomas, Klein, Tang (bib92) 2011; 17 Morrow, Antman (bib18) 2009; 55 Emerging Risk Factors Collaboration, Kaptoge, Di Angelantonio, Pennells L Wood, White, Gao (bib30) 2012; 367 D׳Agostino, Grundy, Sullivan, Wilson, CHD Risk Prediction Group (bib24) 2001; 286 La Thangue, Kerr (bib11) 2011; 8 Beatty, Zhang, Ku, Na, Schiller, Whooley (bib130) 2012; 220 Januzzi, Peacock, Maisel, Chae, Jesse, Baggish (bib103) 2007; 50 Kaplan, Aviles-Santa, Parrinello, Hanna, Jung, Castaneda (bib22) 2014; 3 Maisel, Xue, Shah, Mueller, Nowak, Peacock (bib86) 2011; 4 Sunderman (bib19) 1975; 21 Gupta, Singh, Verma (bib20) 2006; 113 Cox (bib33) 1972; 34 Takase, Dohi (bib76) 2014; 44 Thum (10.1016/j.tcm.2016.07.005_bib122) 2007; 116 Collins (10.1016/j.tcm.2016.07.005_bib10) 2015; 372 La Thangue (10.1016/j.tcm.2016.07.005_bib11) 2011; 8 Sheehy (10.1016/j.tcm.2016.07.005_bib45) 2009; 2 Schlittenhardt (10.1016/j.tcm.2016.07.005_bib109) 2004; 318 Bossuyt (10.1016/j.tcm.2016.07.005_bib27) 2003; 49 Friddle (10.1016/j.tcm.2016.07.005_bib44) 2000; 97 Samani (10.1016/j.tcm.2016.07.005_bib54) 2007; 357 Vegter (10.1016/j.tcm.2016.07.005_bib123) 2016; 18 Cox (10.1016/j.tcm.2016.07.005_bib33) 1972; 34 Maisel (10.1016/j.tcm.2016.07.005_bib86) 2011; 4 Wilson (10.1016/j.tcm.2016.07.005_bib62) 2008; 1 van Rooij (10.1016/j.tcm.2016.07.005_bib117) 2008; 105 Thygesen (10.1016/j.tcm.2016.07.005_bib4) 2007; 116 Vasan (10.1016/j.tcm.2016.07.005_bib5) 2006; 113 Fox (10.1016/j.tcm.2016.07.005_bib75) 2011; 124 Akat (10.1016/j.tcm.2016.07.005_bib124) 2014; 111 Care (10.1016/j.tcm.2016.07.005_bib115) 2007; 13 Zeng (10.1016/j.tcm.2016.07.005_bib21) 2014; 112 Sanada (10.1016/j.tcm.2016.07.005_bib100) 2007; 117 Yao (10.1016/j.tcm.2016.07.005_bib66) 2015; 131 Ahmad (10.1016/j.tcm.2016.07.005_bib71) 2014; 2 Ganesh (10.1016/j.tcm.2016.07.005_bib58) 2013; 128 Sabatine (10.1016/j.tcm.2016.07.005_bib102) 2008; 117 Bjerre (10.1016/j.tcm.2016.07.005_bib129) 2013; 20 Srivatsan (10.1016/j.tcm.2016.07.005_bib93) 2015; 22 10.1016/j.tcm.2016.07.005_bib41 Hirschhorn (10.1016/j.tcm.2016.07.005_bib53) 2009; 360 Cook (10.1016/j.tcm.2016.07.005_bib37) 2007; 115 Pascual-Figal (10.1016/j.tcm.2016.07.005_bib105) 2011; 13 Hwang (10.1016/j.tcm.2016.07.005_bib50) 2002; 10 van Kimmenade (10.1016/j.tcm.2016.07.005_bib94) 2006; 48 Calore (10.1016/j.tcm.2016.07.005_bib43) 2015; 89 deFilippi (10.1016/j.tcm.2016.07.005_bib79) 2010; 304 Masson (10.1016/j.tcm.2016.07.005_bib82) 2012; 125 Baker (10.1016/j.tcm.2016.07.005_bib34) 2003; 95 Askevold (10.1016/j.tcm.2016.07.005_bib133) 2013; 6 Nishikimi (10.1016/j.tcm.2016.07.005_bib107) 1995; 26 Tajik (10.1016/j.tcm.2016.07.005_bib13) 2013; 19 Ray (10.1016/j.tcm.2016.07.005_bib61) 2011; 74 Maisel (10.1016/j.tcm.2016.07.005_bib69) 2011; 58 10.1016/j.tcm.2016.07.005_bib74 Shah (10.1016/j.tcm.2016.07.005_bib104) 2009; 2 D׳Agostino (10.1016/j.tcm.2016.07.005_bib23) 2001; 286 Kamath (10.1016/j.tcm.2016.07.005_bib32) 2001; 33 Lott (10.1016/j.tcm.2016.07.005_bib17) 1992; 38 Pepe (10.1016/j.tcm.2016.07.005_bib36) 2000; 56 He (10.1016/j.tcm.2016.07.005_bib114) 2004; 5 D׳Agostino (10.1016/j.tcm.2016.07.005_bib24) 2001; 286 Pham (10.1016/j.tcm.2016.07.005_bib51) 2010; 362 Atkinson (10.1016/j.tcm.2016.07.005_bib6) 2001; 69 Nazer (10.1016/j.tcm.2016.07.005_bib131) 2011; 32 Watson (10.1016/j.tcm.2016.07.005_bib125) 2015; 17 Ueland (10.1016/j.tcm.2016.07.005_bib128) 2004; 44 10.1016/j.tcm.2016.07.005_bib63 Tonelli (10.1016/j.tcm.2016.07.005_bib134) 2008; 117 Neuhold (10.1016/j.tcm.2016.07.005_bib88) 2008; 52 Huan (10.1016/j.tcm.2016.07.005_bib67) 2015; 35 Deeks (10.1016/j.tcm.2016.07.005_bib15) 2004; 329 Maisel (10.1016/j.tcm.2016.07.005_bib90) 2011; 13 Edelmann (10.1016/j.tcm.2016.07.005_bib97) 2014 Kelly (10.1016/j.tcm.2016.07.005_bib87) 2008; 14 10.1016/j.tcm.2016.07.005_bib9 Kittleson (10.1016/j.tcm.2016.07.005_bib47) 2005; 21 Dhingra (10.1016/j.tcm.2016.07.005_bib98) 2009; 119 Januzzi (10.1016/j.tcm.2016.07.005_bib103) 2007; 50 Mercer (10.1016/j.tcm.2016.07.005_bib126) 2009; 10 Xu (10.1016/j.tcm.2016.07.005_bib110) 2006; 98 Roden (10.1016/j.tcm.2016.07.005_bib42) 2015; 61 Yang (10.1016/j.tcm.2016.07.005_bib48) 2000; 102 Horwich (10.1016/j.tcm.2016.07.005_bib81) 2003; 108 Balagopal (10.1016/j.tcm.2016.07.005_bib2) 2011; 123 Ware (10.1016/j.tcm.2016.07.005_bib29) 2006; 355 Khan (10.1016/j.tcm.2016.07.005_bib85) 2007; 115 Kaplan (10.1016/j.tcm.2016.07.005_bib22) 2014; 3 Fonarow (10.1016/j.tcm.2016.07.005_bib72) 2007; 49 Kumarswamy (10.1016/j.tcm.2016.07.005_bib127) 2014; 114 Shah (10.1016/j.tcm.2016.07.005_bib96) 2010; 12 10.1016/j.tcm.2016.07.005_bib14 The CARD (10.1016/j.tcm.2016.07.005_bib59) 2015; 47 10.1016/j.tcm.2016.07.005_bib1 Kempf (10.1016/j.tcm.2016.07.005_bib111) 2007; 53 Lemeshow (10.1016/j.tcm.2016.07.005_bib25) 1982; 115 McGregor (10.1016/j.tcm.2016.07.005_bib60) 2006; 98 Steyerberg (10.1016/j.tcm.2016.07.005_bib40) 2010; 21 Saunders (10.1016/j.tcm.2016.07.005_bib80) 2011; 123 Khan (10.1016/j.tcm.2016.07.005_bib78) 2008; 51 Lander (10.1016/j.tcm.2016.07.005_bib52) 1994; 265 Hanley (10.1016/j.tcm.2016.07.005_bib35) 1982; 143 Kempf (10.1016/j.tcm.2016.07.005_bib112) 2007; 50 McMurray (10.1016/j.tcm.2016.07.005_bib73) 2014; 371 Malottki (10.1016/j.tcm.2016.07.005_bib12) 2014; 4 Wang (10.1016/j.tcm.2016.07.005_bib8) 2011; 123 Shrestha (10.1016/j.tcm.2016.07.005_bib92) 2011; 17 Takase (10.1016/j.tcm.2016.07.005_bib76) 2014; 44 de Boer (10.1016/j.tcm.2016.07.005_bib95) 2010; 43 Wang (10.1016/j.tcm.2016.07.005_bib31) 2006; 355 Kjeldsen (10.1016/j.tcm.2016.07.005_bib89) 1993; 268 Braunwald (10.1016/j.tcm.2016.07.005_bib68) 2008; 358 Shimpo (10.1016/j.tcm.2016.07.005_bib101) 2004; 109 Hardy (10.1016/j.tcm.2016.07.005_bib56) 2009; 360 Maisel (10.1016/j.tcm.2016.07.005_bib77) 2010; 55 Melman (10.1016/j.tcm.2016.07.005_bib119) 2014; 7 Daniels (10.1016/j.tcm.2016.07.005_bib70) 2015; 12 Stanton (10.1016/j.tcm.2016.07.005_bib46) 2000; 86 Pencina (10.1016/j.tcm.2016.07.005_bib39) 2011; 30 Daniels (10.1016/j.tcm.2016.07.005_bib113) 2011; 123 Emerging Risk Factors Collaboration (10.1016/j.tcm.2016.07.005_bib30) 2012; 367 Morrow (10.1016/j.tcm.2016.07.005_bib18) 2009; 55 Jougasaki (10.1016/j.tcm.2016.07.005_bib108) 1996; 97 Melman (10.1016/j.tcm.2016.07.005_bib120) 2015; 131 Zolk (10.1016/j.tcm.2016.07.005_bib132) 2002; 106 McShane (10.1016/j.tcm.2016.07.005_bib28) 2005; 23 Kittleson (10.1016/j.tcm.2016.07.005_bib49) 2004; 110 Tijsen (10.1016/j.tcm.2016.07.005_bib118) 2012; 93 Goff (10.1016/j.tcm.2016.07.005_bib3) 2014; 129 Solberg (10.1016/j.tcm.2016.07.005_bib16) 1987; 25 Gupta (10.1016/j.tcm.2016.07.005_bib20) 2006; 113 Xue (10.1016/j.tcm.2016.07.005_bib84) 2011; 13 Thum (10.1016/j.tcm.2016.07.005_bib116) 2008; 456 O׳Meara (10.1016/j.tcm.2016.07.005_bib99) 2013; 10 Ovchinnikova (10.1016/j.tcm.2016.07.005_bib121) 2016; 18 Ronsein (10.1016/j.tcm.2016.07.005_bib64) 2015; 113 Paynter (10.1016/j.tcm.2016.07.005_bib57) 2009; 150 Nymo (10.1016/j.tcm.2016.07.005_bib91) 2012; 271 Peacock (10.1016/j.tcm.2016.07.005_bib83) 2008; 358 Pencina (10.1016/j.tcm.2016.07.005_bib38) 2008; 27 Hlatky (10.1016/j.tcm.2016.07.005_bib7) 2009; 119 Napoli (10.1016/j.tcm.2016.07.005_bib65) 2013; 114 Wade (10.1016/j.tcm.2016.07.005_bib26) 2000; 83 Myocardial Infarction Genetic Consortium (10.1016/j.tcm.2016.07.005_bib55) 2009; 41 Jougasaki (10.1016/j.tcm.2016.07.005_bib106) 1995; 92 Sunderman (10.1016/j.tcm.2016.07.005_bib19) 1975; 21 Beatty (10.1016/j.tcm.2016.07.005_bib130) 2012; 220 27666742 - Trends Cardiovasc Med. 2017 Feb;27(2):134-135. doi: 10.1016/j.tcm.2016.08.004. |
| References_xml | – volume: 47 start-page: 1121 year: 2015 end-page: 1130 ident: bib59 article-title: A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease publication-title: Nat Genet – volume: 131 start-page: 536 year: 2015 end-page: 549 ident: bib66 article-title: Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes publication-title: Circulation – volume: 4 start-page: 613 year: 2011 end-page: 620 ident: bib86 article-title: Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the biomarkers in acute heart failure (BACH) study publication-title: Circ Heart Fail – volume: 98 start-page: 342 year: 2006 end-page: 350 ident: bib110 article-title: GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation publication-title: Circ Res – volume: 7 start-page: 203 year: 2014 end-page: 214 ident: bib119 article-title: MicroRNAs in heart failure: is the picture becoming less miRky? publication-title: Circ Heart Fail – reference: [accessed 23.07.16]. – volume: 13 start-page: 846 year: 2011 end-page: 851 ident: bib90 article-title: Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial publication-title: Eur J Heart Fail – volume: 23 start-page: 9067 year: 2005 end-page: 9072 ident: bib28 article-title: Reporting recommendations for tumor marker prognostic studies publication-title: J Clin Oncol – volume: 271 start-page: 436 year: 2012 end-page: 443 ident: bib91 article-title: The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA publication-title: J Intern Med – volume: 113 start-page: 388 year: 2015 end-page: 399 ident: bib64 article-title: Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics publication-title: J Proteomics – volume: 129 start-page: S49 year: 2014 end-page: S73 ident: bib3 article-title: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: Circulation – volume: 143 start-page: 29 year: 1982 end-page: 36 ident: bib35 article-title: The meaning and use of the area under a receiver operating characteristic (ROC) curve publication-title: Radiology – volume: 3 start-page: e000923 year: 2014 ident: bib22 article-title: Body mass index, sex, and cardiovascular disease risk factors among hispanic/latino adults: hispanic community health study/study of latinos publication-title: J Am Heart Assoc – volume: 61 start-page: 79 year: 2015 end-page: 85 ident: bib42 article-title: Cardiovascular pharmacogenomics: current status and future directions publication-title: J Hum Genet – volume: 25 start-page: 337 year: 1987 end-page: 342 ident: bib16 article-title: International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values publication-title: J Clin Chem Clin Biochem – volume: 58 start-page: 1890 year: 2011 end-page: 1892 ident: bib69 article-title: Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research publication-title: J Am Coll Cardiol – volume: 17 start-page: 472 year: 2011 end-page: 478 ident: bib92 article-title: Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase associated lipocalin levels than myocardial dysfunction in systolic heart failure publication-title: J Card Fail – volume: 97 start-page: 2370 year: 1996 end-page: 2376 ident: bib108 article-title: Cardiac secretion of adrenomedullin in human heart failure publication-title: J Clin Invest – volume: 50 start-page: 607 year: 2007 end-page: 613 ident: bib103 article-title: Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (pro-brain natriuretic peptide investigation of dyspnea in the emergency department) Study publication-title: J Am Coll Cardiol – volume: 86 start-page: 939 year: 2000 end-page: 945 ident: bib46 article-title: Altered patterns of gene expression in response to myocardial infarction. publication-title: Circ Res – volume: 108 start-page: 833 year: 2003 end-page: 838 ident: bib81 article-title: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure publication-title: Circulation – volume: 10 start-page: 31 year: 2002 end-page: 44 ident: bib50 article-title: Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure publication-title: Physiol Genomics – volume: 21 start-page: 1873 year: 1975 end-page: 1877 ident: bib19 article-title: Current concepts of “Normal Values,” “Reference Values,” and “Discrimination Values” in clinical chemistry publication-title: Clin Chem – volume: 362 start-page: 1890 year: 2010 end-page: 1900 ident: bib51 article-title: Gene-expression profiling for rejection surveillance after cardiac transplantation publication-title: N Engl J Med – volume: 52 start-page: 266 year: 2008 end-page: 272 ident: bib88 article-title: Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease publication-title: J Am Coll Cardiol – volume: 44 start-page: 1970 year: 2004 end-page: 1976 ident: bib128 article-title: Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction publication-title: J Am Coll Cardiol – volume: 32 start-page: 1390 year: 2011 end-page: 1397 ident: bib131 article-title: Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome publication-title: Eur Heart J – volume: 49 start-page: 1943 year: 2007 end-page: 1950 ident: bib72 article-title: Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure publication-title: J Am Coll Cardiol – volume: 367 start-page: 1310 year: 2012 end-page: 1320 ident: bib30 article-title: C-reactive protein, fibrinogen, and cardiovascular disease prediction publication-title: N Engl J Med – volume: 92 start-page: 286 year: 1995 end-page: 289 ident: bib106 article-title: Elevation of circulating and ventricular adrenomedullin in human congestive heart failure publication-title: Circulation – volume: 33 start-page: 464 year: 2001 end-page: 470 ident: bib32 article-title: A model to predict survival in patients with end-stage liver disease publication-title: Hepatology – volume: 49 start-page: 1 year: 2003 end-page: 6 ident: bib27 article-title: Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative publication-title: Clin Chem – volume: 12 start-page: 826 year: 2010 end-page: 832 ident: bib96 article-title: Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure publication-title: Eur J Heart Fail – volume: 220 start-page: 587 year: 2012 end-page: 592 ident: bib130 article-title: Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the heart and soul study publication-title: Atherosclerosis – volume: 111 start-page: 11151 year: 2014 end-page: 11156 ident: bib124 article-title: Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers publication-title: Proc Natl Acad Sci – volume: 50 start-page: 1054 year: 2007 end-page: 1060 ident: bib112 article-title: Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure publication-title: J Am Coll Cardiol – volume: 109 start-page: 2186 year: 2004 end-page: 2190 ident: bib101 article-title: Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction publication-title: Circulation – volume: 53 start-page: 284 year: 2007 end-page: 291 ident: bib111 article-title: Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay publication-title: Clin Chem – reference: Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, Khan AM, et al. Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol 108:979–984. – volume: 286 start-page: 180 year: 2001 end-page: 187 ident: bib24 article-title: Validation of the framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation publication-title: J Am Med Assoc – volume: 357 start-page: 443 year: 2007 end-page: 453 ident: bib54 article-title: Genomewide association analysis of coronary artery disease publication-title: N Engl J Med – volume: 123 start-page: 551 year: 2011 end-page: 565 ident: bib8 article-title: Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction publication-title: Circulation – volume: 371 start-page: 993 year: 2014 end-page: 1004 ident: bib73 article-title: Angiotensin + neprilysin inhibition versus enalapril in heart failure publication-title: N Engl J Med – volume: 51 start-page: 1857 year: 2008 end-page: 1864 ident: bib78 article-title: Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (leicester acute myocardial infarction peptide) study publication-title: J Am Coll Cardiol – volume: 116 start-page: 2634 year: 2007 end-page: 2653 ident: bib4 article-title: Universal Definition of Myocardial Infarction publication-title: Circulation – volume: 304 start-page: 2494 year: 2010 end-page: 2502 ident: bib79 article-title: Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults publication-title: J Am Med Assoc – volume: 372 start-page: 793 year: 2015 end-page: 795 ident: bib10 article-title: A new initiative on precision medicine publication-title: N Engl J Med – volume: 13 start-page: 613 year: 2007 end-page: 618 ident: bib115 article-title: MicroRNA-133 controls cardiac hypertrophy publication-title: Nat Med – volume: 131 start-page: 2202 year: 2015 end-page: 2216 ident: bib120 article-title: Circulating microRNA-30D is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study publication-title: Circulation – volume: 35 start-page: 1011 year: 2015 end-page: 1021 ident: bib67 article-title: Dissecting the roles of micrornas in coronary heart disease via integrative genomic analyses publication-title: Arterioscler Thromb Vasc Biol – volume: 98 start-page: 309 year: 2006 end-page: 321 ident: bib60 article-title: Proteomics of the heart: unraveling disease publication-title: Circ Res – volume: 123 start-page: 1367 year: 2011 end-page: 1376 ident: bib80 article-title: Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study publication-title: Circulation – volume: 83 start-page: 459 year: 2000 end-page: 460 ident: bib26 article-title: Derivation versus validation publication-title: Arch Dis Child – volume: 13 start-page: 37 year: 2011 end-page: 42 ident: bib84 article-title: Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure publication-title: Eur J Heart Fail – volume: 27 start-page: 157 year: 2008 end-page: 172 ident: bib38 article-title: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond publication-title: Stat Med – volume: 114 start-page: 7 year: 2013 end-page: 20 ident: bib65 article-title: Recent advances in proteomic technologies applied to cardiovascular disease publication-title: J Cell Biochem – volume: 117 start-page: 1936 year: 2008 end-page: 1944 ident: bib102 article-title: Complementary roles for biomarkers of biomechanical strain ST2 and n-terminal prohormone B-type natriuretic peptide in patients with st-elevation myocardial infarction publication-title: Circulation – volume: 19 start-page: 4578 year: 2013 end-page: 4588 ident: bib13 article-title: Trial designs for personalizing cancer care: a systematic review and classification publication-title: Clin Cancer Res – volume: 112 start-page: 1735 year: 2014 end-page: 1744 ident: bib21 article-title: Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults publication-title: Br J Nutr – volume: 17 start-page: 405 year: 2015 end-page: 415 ident: bib125 article-title: MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure publication-title: Eur J Heart Fail – volume: 2 start-page: 116 year: 2009 end-page: 124 ident: bib45 article-title: Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy publication-title: Circ Cardiovasc Genet – volume: 10 start-page: 350 year: 2013 end-page: 358 ident: bib99 article-title: Circulating biomarkers in patients with heart failure and preserved ejection fraction publication-title: Curr Heart Fail Rep – volume: 38 start-page: 648 year: 1992 end-page: 650 ident: bib17 article-title: Estimation of reference ranges: how many subjects are needed? publication-title: Clin Chem – volume: 355 start-page: 2615 year: 2006 end-page: 2617 ident: bib29 article-title: The limitations of risk factors as prognostic tools publication-title: N Engl J Med – volume: 329 start-page: 168 year: 2004 end-page: 169 ident: bib15 article-title: Diagnostic tests 4: likelihood ratios publication-title: Br Med J – volume: 110 start-page: 3444 year: 2004 end-page: 3451 ident: bib49 article-title: Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy publication-title: Circulation – reference: [accessed 19.07.16]. – volume: 30 start-page: 11 year: 2011 end-page: 21 ident: bib39 article-title: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers publication-title: Stat Med – volume: 265 start-page: 2037 year: 1994 end-page: 2048 ident: bib52 article-title: Genetic dissection of complex traits publication-title: Science – volume: 123 start-page: 2101 year: 2011 end-page: 2110 ident: bib113 article-title: Growth-differentiation factor-15 is a robust, independent predictor of 11-Year mortality risk in community-dwelling older adults: The Rancho Bernardo Study publication-title: Circulation – volume: 55 start-page: 5 year: 2009 end-page: 8 ident: bib18 article-title: Evaluation of high-sensitivity assays for cardiac troponin publication-title: Clin Chem – volume: 18 start-page: 414 year: 2016 end-page: 423 ident: bib121 article-title: Signature of circulating microRNAs in patients with acute heart failure publication-title: Eur J Heart Fail – volume: 56 start-page: 352 year: 2000 end-page: 359 ident: bib36 article-title: An interpretation for the ROC curve and inference using GLM procedures publication-title: Biometrics – volume: 21 start-page: 299 year: 2005 end-page: 307 ident: bib47 article-title: Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure publication-title: Physiol Genomics – volume: 286 start-page: 180 year: 2001 end-page: 187 ident: bib23 article-title: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation publication-title: J Am Med Assoc – volume: 119 start-page: 2408 year: 2009 end-page: 2416 ident: bib7 article-title: Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association publication-title: Circulation – volume: 360 start-page: 1759 year: 2009 end-page: 1768 ident: bib56 article-title: Genomewide association studies and human disease publication-title: N Engl J Med – volume: 358 start-page: 2117 year: 2008 end-page: 2126 ident: bib83 article-title: Cardiac troponin and outcome in acute heart failure publication-title: N Engl J Med – volume: 268 start-page: 10425 year: 1993 end-page: 10432 ident: bib89 article-title: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase publication-title: J Biol Chem – volume: 124 start-page: 1021 year: 2011 end-page: 1027 ident: bib75 article-title: Relation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson Heart Study publication-title: Circulation – volume: 2 start-page: 311 year: 2009 end-page: 319 ident: bib104 article-title: Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea publication-title: Circ Heart Fail – volume: 117 start-page: 163 year: 2008 end-page: 168 ident: bib134 article-title: Relation Between red blood cell distribution width and cardiovascular event rate in people with coronary disease publication-title: Circulation – volume: 2 start-page: 477 year: 2014 end-page: 488 ident: bib71 article-title: Charting a roadmap for heart failure biomarker studies publication-title: JACC Heart Fail – volume: 14 start-page: 739 year: 2008 end-page: 745 ident: bib87 article-title: C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction publication-title: J Card Fail – volume: 115 start-page: 2103 year: 2007 end-page: 2110 ident: bib85 article-title: C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: leicester acute myocardial infarction peptide (LAMP) study publication-title: Circulation – volume: 115 start-page: 928 year: 2007 end-page: 935 ident: bib37 article-title: Use and misuse of the receiver operating characteristic curve in risk prediction publication-title: Circulation – volume: 150 start-page: 65 year: 2009 end-page: 72 ident: bib57 article-title: Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3 publication-title: Ann Intern Med – year: 2014 ident: bib97 article-title: Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial publication-title: Eur J Heart Fail – volume: 115 start-page: 92 year: 1982 end-page: 106 ident: bib25 article-title: . A review of goodness of fit statistics for use in the development of logistic regression models publication-title: Am J Epidemiol – volume: 128 start-page: 2813 year: 2013 end-page: 2851 ident: bib58 article-title: Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association publication-title: Circulation – volume: 55 start-page: 2062 year: 2010 end-page: 2076 ident: bib77 article-title: Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (biomarkers in acute heart failure) trial publication-title: J Am Coll Cardiol – volume: 95 start-page: 511 year: 2003 end-page: 515 ident: bib34 article-title: The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer publication-title: J Natl Cancer Inst – volume: 360 start-page: 1699 year: 2009 end-page: 1701 ident: bib53 article-title: Genomewide association studies GÇö illuminating biologic pathways publication-title: N Engl J Med – volume: 123 start-page: 2749 year: 2011 end-page: 2769 ident: bib2 article-title: Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association publication-title: Circulation – volume: 48 start-page: 1217 year: 2006 end-page: 1224 ident: bib94 article-title: Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure publication-title: J Am Coll Cardiol – volume: 13 start-page: 718 year: 2011 end-page: 725 ident: bib105 article-title: Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure publication-title: Eur J Heart Fail – volume: 74 start-page: 2660 year: 2011 end-page: 2681 ident: bib61 article-title: Emerging nanoproteomics approaches for disease biomarker detection: a current perspective publication-title: J Proteomics – volume: 26 start-page: 1424 year: 1995 end-page: 1431 ident: bib107 article-title: Increased plasma levels of adrenomedullin in patients with heart failure publication-title: J Am Coll Cardiol – volume: 1 start-page: 141 year: 2008 end-page: 146 ident: bib62 article-title: Progressing from risk factors to omics publication-title: . Circ Cardiovasc Genet – volume: 117 start-page: 1538 year: 2007 end-page: 1549 ident: bib100 article-title: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system publication-title: J Clin Invest – volume: 8 start-page: 587 year: 2011 end-page: 596 ident: bib11 article-title: Predictive biomarkers: a paradigm shift towards personalized cancer medicine publication-title: Nat Rev Clin Oncol – volume: 43 start-page: 60 year: 2010 end-page: 68 ident: bib95 article-title: Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction publication-title: Ann Med – volume: 456 start-page: 980 year: 2008 end-page: 984 ident: bib116 article-title: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts publication-title: Nature – volume: 44 start-page: 303 year: 2014 end-page: 308 ident: bib76 article-title: Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship publication-title: Eur J Clin Invest – volume: 114 start-page: 1569 year: 2014 end-page: 1575 ident: bib127 article-title: Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure publication-title: Circ Res – volume: 20 start-page: 922 year: 2013 end-page: 929 ident: bib129 article-title: High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention. publication-title: Eur J Prev Cardiol – volume: 41 start-page: 334 year: 2009 end-page: 341 ident: bib55 article-title: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants publication-title: Nat Genet – volume: 22 start-page: 1096 year: 2015 end-page: 1110 ident: bib93 article-title: Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand? publication-title: Eur J Prev Cardiol – volume: 106 start-page: 1442 year: 2002 end-page: 1446 ident: bib132 article-title: Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance publication-title: Circulation – volume: 4 start-page: e004188 year: 2014 ident: bib12 article-title: Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers publication-title: BMJ Open – volume: 21 start-page: 128 year: 2010 end-page: 138 ident: bib40 article-title: Assessing the performance of prediction models: a framework for traditional and novel measures publication-title: Epidemiology – volume: 97 start-page: 6745 year: 2000 end-page: 6750 ident: bib44 article-title: Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy publication-title: Proc Natl Acad Sci – volume: 116 start-page: 258 year: 2007 end-page: 267 ident: bib122 article-title: MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure publication-title: Circulation – volume: 12 start-page: 588 year: 2015 end-page: 596 ident: bib70 article-title: Cardiovascular biomarkers and sex: the case for women publication-title: Nat Rev Cardiol – volume: 125 start-page: 280 year: 2012 end-page: 288 ident: bib82 article-title: Serial measurement of cardiac troponin t using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials publication-title: Circulation – volume: 5 start-page: 522 year: 2004 end-page: 531 ident: bib114 article-title: MicroRNAs: small RNAs with a big role in gene regulation publication-title: Nat Rev Genet – volume: 355 start-page: 2631 year: 2006 end-page: 2639 ident: bib31 article-title: Multiple biomarkers for the prediction of first major cardiovascular events and death publication-title: N Engl J Med – volume: 102 start-page: 3046 year: 2000 end-page: 3052 ident: bib48 article-title: Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays publication-title: Circulation – volume: 358 start-page: 2148 year: 2008 end-page: 2159 ident: bib68 article-title: Biomarkers in heart failure publication-title: N Engl J Med – volume: 119 start-page: 1101 year: 2009 end-page: 1107 ident: bib98 article-title: Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community publication-title: Circulation – volume: 113 start-page: e924 year: 2006 end-page: e929 ident: bib20 article-title: South Asians and cardiovascular risk: what clinicians should know publication-title: Circulation – volume: 6 start-page: 91 year: 2013 end-page: 98 ident: bib133 article-title: Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA) publication-title: Circ Heart Fail – volume: 89 start-page: 27 year: 2015 end-page: 34 ident: bib43 article-title: Genetics meets epigenetics: genetic variants that modulate noncoding RNA in cardiovascular diseases publication-title: J Mol Cell Cardiol – volume: 69 start-page: 89 year: 2001 end-page: 95 ident: bib6 article-title: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework publication-title: Clin Pharmacol Ther – volume: 318 start-page: 325 year: 2004 end-page: 333 ident: bib109 article-title: Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions publication-title: Cell Tissue Res – volume: 113 start-page: 2335 year: 2006 end-page: 2362 ident: bib5 article-title: Biomarkers of cardiovascular disease: molecular basis and practical considerations publication-title: Circulation – volume: 105 start-page: 13027 year: 2008 end-page: 13032 ident: bib117 article-title: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis publication-title: Proc Natl Acad Sci – volume: 34 start-page: 187 year: 1972 end-page: 220 ident: bib33 article-title: Regression models and life tables. publication-title: J R Stat Soc – volume: 93 start-page: 573 year: 2012 end-page: 582 ident: bib118 article-title: Non-cardiomyocyte microRNAs in heart failure publication-title: Cardiovasc Res – volume: 18 start-page: 457 year: 2016 end-page: 468 ident: bib123 article-title: MicroRNAs in heart failure: from biomarker to target for therapy publication-title: Eur J Heart Fail – volume: 10 start-page: 155 year: 2009 end-page: 159 ident: bib126 article-title: Long non-coding RNAs: insights into functions publication-title: Nat Rev Genet – volume: 115 start-page: 92 year: 1982 ident: 10.1016/j.tcm.2016.07.005_bib25 article-title: . A review of goodness of fit statistics for use in the development of logistic regression models publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a113284 – volume: 105 start-page: 13027 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib117 article-title: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.0805038105 – volume: 14 start-page: 739 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib87 article-title: C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction publication-title: J Card Fail doi: 10.1016/j.cardfail.2008.07.231 – volume: 143 start-page: 29 year: 1982 ident: 10.1016/j.tcm.2016.07.005_bib35 article-title: The meaning and use of the area under a receiver operating characteristic (ROC) curve publication-title: Radiology doi: 10.1148/radiology.143.1.7063747 – volume: 113 start-page: 388 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib64 article-title: Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics publication-title: J Proteomics doi: 10.1016/j.jprot.2014.10.017 – volume: 30 start-page: 11 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib39 article-title: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers publication-title: Stat Med doi: 10.1002/sim.4085 – volume: 2 start-page: 311 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib104 article-title: Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.108.833707 – volume: 86 start-page: 939 year: 2000 ident: 10.1016/j.tcm.2016.07.005_bib46 article-title: Altered patterns of gene expression in response to myocardial infarction. publication-title: Circ Res doi: 10.1161/01.RES.86.9.939 – volume: 97 start-page: 6745 year: 2000 ident: 10.1016/j.tcm.2016.07.005_bib44 article-title: Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.100127897 – volume: 26 start-page: 1424 year: 1995 ident: 10.1016/j.tcm.2016.07.005_bib107 article-title: Increased plasma levels of adrenomedullin in patients with heart failure publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(95)00338-X – volume: 10 start-page: 350 year: 2013 ident: 10.1016/j.tcm.2016.07.005_bib99 article-title: Circulating biomarkers in patients with heart failure and preserved ejection fraction publication-title: Curr Heart Fail Rep doi: 10.1007/s11897-013-0160-x – volume: 318 start-page: 325 year: 2004 ident: 10.1016/j.tcm.2016.07.005_bib109 article-title: Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions publication-title: Cell Tissue Res doi: 10.1007/s00441-004-0986-3 – volume: 12 start-page: 588 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib70 article-title: Cardiovascular biomarkers and sex: the case for women publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2015.105 – volume: 131 start-page: 536 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib66 article-title: Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.010696 – volume: 119 start-page: 1101 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib98 article-title: Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.821769 – volume: 117 start-page: 163 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib134 article-title: Relation Between red blood cell distribution width and cardiovascular event rate in people with coronary disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.727545 – volume: 55 start-page: 2062 year: 2010 ident: 10.1016/j.tcm.2016.07.005_bib77 article-title: Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (biomarkers in acute heart failure) trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.02.025 – volume: 304 start-page: 2494 year: 2010 ident: 10.1016/j.tcm.2016.07.005_bib79 article-title: Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults publication-title: J Am Med Assoc doi: 10.1001/jama.2010.1708 – volume: 131 start-page: 2202 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib120 article-title: Circulating microRNA-30D is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.013220 – volume: 50 start-page: 1054 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib112 article-title: Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.04.091 – volume: 38 start-page: 648 year: 1992 ident: 10.1016/j.tcm.2016.07.005_bib17 article-title: Estimation of reference ranges: how many subjects are needed? publication-title: Clin Chem doi: 10.1093/clinchem/38.5.648 – volume: 113 start-page: 2335 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib5 article-title: Biomarkers of cardiovascular disease: molecular basis and practical considerations publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.104.482570 – volume: 41 start-page: 334 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib55 article-title: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants publication-title: Nat Genet doi: 10.1038/ng.327 – volume: 13 start-page: 846 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib90 article-title: Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfr087 – volume: 371 start-page: 993 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib73 article-title: Angiotensin + neprilysin inhibition versus enalapril in heart failure publication-title: N Engl J Med doi: 10.1056/NEJMoa1409077 – volume: 61 start-page: 79 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib42 article-title: Cardiovascular pharmacogenomics: current status and future directions publication-title: J Hum Genet doi: 10.1038/jhg.2015.78 – volume: 95 start-page: 511 year: 2003 ident: 10.1016/j.tcm.2016.07.005_bib34 article-title: The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/95.7.511 – volume: 4 start-page: 613 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib86 article-title: Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the biomarkers in acute heart failure (BACH) study publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.110.960096 – volume: 48 start-page: 1217 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib94 article-title: Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.03.061 – ident: 10.1016/j.tcm.2016.07.005_bib41 – volume: 109 start-page: 2186 year: 2004 ident: 10.1016/j.tcm.2016.07.005_bib101 article-title: Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction publication-title: Circulation doi: 10.1161/01.CIR.0000127958.21003.5A – volume: 18 start-page: 414 year: 2016 ident: 10.1016/j.tcm.2016.07.005_bib121 article-title: Signature of circulating microRNAs in patients with acute heart failure publication-title: Eur J Heart Fail doi: 10.1002/ejhf.332 – volume: 12 start-page: 826 year: 2010 ident: 10.1016/j.tcm.2016.07.005_bib96 article-title: Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfq091 – volume: 47 start-page: 1121 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib59 article-title: A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease publication-title: Nat Genet doi: 10.1038/ng.3396 – volume: 128 start-page: 2813 year: 2013 ident: 10.1016/j.tcm.2016.07.005_bib58 article-title: Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/01.cir.0000437913.98912.1d – volume: 2 start-page: 477 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib71 article-title: Charting a roadmap for heart failure biomarker studies publication-title: JACC Heart Fail doi: 10.1016/j.jchf.2014.02.005 – volume: 10 start-page: 155 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib126 article-title: Long non-coding RNAs: insights into functions publication-title: Nat Rev Genet doi: 10.1038/nrg2521 – volume: 49 start-page: 1943 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib72 article-title: Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.02.037 – volume: 115 start-page: 928 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib37 article-title: Use and misuse of the receiver operating characteristic curve in risk prediction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.672402 – volume: 265 start-page: 2037 year: 1994 ident: 10.1016/j.tcm.2016.07.005_bib52 article-title: Genetic dissection of complex traits publication-title: Science doi: 10.1126/science.8091226 – volume: 83 start-page: 459 year: 2000 ident: 10.1016/j.tcm.2016.07.005_bib26 article-title: Derivation versus validation publication-title: Arch Dis Child doi: 10.1136/adc.83.6.459 – volume: 13 start-page: 613 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib115 article-title: MicroRNA-133 controls cardiac hypertrophy publication-title: Nat Med doi: 10.1038/nm1582 – volume: 5 start-page: 522 year: 2004 ident: 10.1016/j.tcm.2016.07.005_bib114 article-title: MicroRNAs: small RNAs with a big role in gene regulation publication-title: Nat Rev Genet doi: 10.1038/nrg1379 – ident: 10.1016/j.tcm.2016.07.005_bib74 doi: 10.1016/j.amjcard.2011.05.033 – volume: 52 start-page: 266 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib88 article-title: Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.03.050 – volume: 92 start-page: 286 year: 1995 ident: 10.1016/j.tcm.2016.07.005_bib106 article-title: Elevation of circulating and ventricular adrenomedullin in human congestive heart failure publication-title: Circulation doi: 10.1161/01.CIR.92.3.286 – volume: 358 start-page: 2148 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib68 article-title: Biomarkers in heart failure publication-title: N Engl J Med doi: 10.1056/NEJMra0800239 – volume: 44 start-page: 303 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib76 article-title: Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship publication-title: Eur J Clin Invest doi: 10.1111/eci.12234 – volume: 56 start-page: 352 year: 2000 ident: 10.1016/j.tcm.2016.07.005_bib36 article-title: An interpretation for the ROC curve and inference using GLM procedures publication-title: Biometrics doi: 10.1111/j.0006-341X.2000.00352.x – volume: 21 start-page: 299 year: 2005 ident: 10.1016/j.tcm.2016.07.005_bib47 article-title: Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00255.2004 – volume: 123 start-page: 1367 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib80 article-title: Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.005264 – volume: 110 start-page: 3444 year: 2004 ident: 10.1016/j.tcm.2016.07.005_bib49 article-title: Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy publication-title: Circulation doi: 10.1161/01.CIR.0000148178.19465.11 – volume: 89 start-page: 27 issue: Pt A year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib43 article-title: Genetics meets epigenetics: genetic variants that modulate noncoding RNA in cardiovascular diseases publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2015.10.028 – volume: 129 start-page: S49 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib3 article-title: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: Circulation doi: 10.1161/01.cir.0000437741.48606.98 – volume: 13 start-page: 37 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib84 article-title: Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfq210 – volume: 21 start-page: 128 year: 2010 ident: 10.1016/j.tcm.2016.07.005_bib40 article-title: Assessing the performance of prediction models: a framework for traditional and novel measures publication-title: Epidemiology doi: 10.1097/EDE.0b013e3181c30fb2 – volume: 114 start-page: 7 year: 2013 ident: 10.1016/j.tcm.2016.07.005_bib65 article-title: Recent advances in proteomic technologies applied to cardiovascular disease publication-title: J Cell Biochem doi: 10.1002/jcb.24307 – volume: 74 start-page: 2660 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib61 article-title: Emerging nanoproteomics approaches for disease biomarker detection: a current perspective publication-title: J Proteomics doi: 10.1016/j.jprot.2011.04.027 – volume: 117 start-page: 1538 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib100 article-title: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system publication-title: J Clin Invest doi: 10.1172/JCI30634 – volume: 2 start-page: 116 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib45 article-title: Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy publication-title: Circ Cardiovasc Genet doi: 10.1161/CIRCGENETICS.108.806935 – ident: 10.1016/j.tcm.2016.07.005_bib63 – volume: 123 start-page: 2101 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib113 article-title: Growth-differentiation factor-15 is a robust, independent predictor of 11-Year mortality risk in community-dwelling older adults: The Rancho Bernardo Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.979740 – volume: 116 start-page: 2634 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib4 article-title: Universal Definition of Myocardial Infarction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.187397 – volume: 53 start-page: 284 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib111 article-title: Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay publication-title: Clin Chem doi: 10.1373/clinchem.2006.076828 – volume: 32 start-page: 1390 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib131 article-title: Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome publication-title: Eur Heart J doi: 10.1093/eurheartj/ehr032 – volume: 8 start-page: 587 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib11 article-title: Predictive biomarkers: a paradigm shift towards personalized cancer medicine publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2011.121 – ident: 10.1016/j.tcm.2016.07.005_bib14 – year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib97 article-title: Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial publication-title: Eur J Heart Fail – volume: 21 start-page: 1873 year: 1975 ident: 10.1016/j.tcm.2016.07.005_bib19 article-title: Current concepts of “Normal Values,” “Reference Values,” and “Discrimination Values” in clinical chemistry publication-title: Clin Chem doi: 10.1093/clinchem/21.13.1873 – volume: 18 start-page: 457 year: 2016 ident: 10.1016/j.tcm.2016.07.005_bib123 article-title: MicroRNAs in heart failure: from biomarker to target for therapy publication-title: Eur J Heart Fail doi: 10.1002/ejhf.495 – volume: 97 start-page: 2370 year: 1996 ident: 10.1016/j.tcm.2016.07.005_bib108 article-title: Cardiac secretion of adrenomedullin in human heart failure publication-title: J Clin Invest doi: 10.1172/JCI118680 – volume: 25 start-page: 337 year: 1987 ident: 10.1016/j.tcm.2016.07.005_bib16 publication-title: J Clin Chem Clin Biochem – volume: 98 start-page: 342 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib110 article-title: GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation publication-title: Circ Res doi: 10.1161/01.RES.0000202804.84885.d0 – volume: 13 start-page: 718 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib105 article-title: Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfr047 – volume: 113 start-page: e924 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib20 article-title: South Asians and cardiovascular risk: what clinicians should know publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.583815 – volume: 33 start-page: 464 year: 2001 ident: 10.1016/j.tcm.2016.07.005_bib32 article-title: A model to predict survival in patients with end-stage liver disease publication-title: Hepatology doi: 10.1053/jhep.2001.22172 – volume: 93 start-page: 573 year: 2012 ident: 10.1016/j.tcm.2016.07.005_bib118 article-title: Non-cardiomyocyte microRNAs in heart failure publication-title: Cardiovasc Res doi: 10.1093/cvr/cvr344 – volume: 35 start-page: 1011 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib67 article-title: Dissecting the roles of micrornas in coronary heart disease via integrative genomic analyses publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.114.305176 – volume: 17 start-page: 405 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib125 article-title: MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure publication-title: Eur J Heart Fail doi: 10.1002/ejhf.244 – volume: 372 start-page: 793 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib10 article-title: A new initiative on precision medicine publication-title: N Engl J Med doi: 10.1056/NEJMp1500523 – volume: 116 start-page: 258 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib122 article-title: MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.687947 – volume: 117 start-page: 1936 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib102 article-title: Complementary roles for biomarkers of biomechanical strain ST2 and n-terminal prohormone B-type natriuretic peptide in patients with st-elevation myocardial infarction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.728022 – volume: 124 start-page: 1021 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib75 article-title: Relation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson Heart Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.991943 – volume: 23 start-page: 9067 year: 2005 ident: 10.1016/j.tcm.2016.07.005_bib28 article-title: Reporting recommendations for tumor marker prognostic studies publication-title: J Clin Oncol doi: 10.1200/JCO.2004.01.0454 – volume: 49 start-page: 1 year: 2003 ident: 10.1016/j.tcm.2016.07.005_bib27 article-title: Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative publication-title: Clin Chem doi: 10.1373/49.1.1 – volume: 27 start-page: 157 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib38 article-title: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond publication-title: Stat Med doi: 10.1002/sim.2929 – volume: 357 start-page: 443 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib54 article-title: Genomewide association analysis of coronary artery disease publication-title: N Engl J Med doi: 10.1056/NEJMoa072366 – volume: 150 start-page: 65 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib57 article-title: Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-2-200901200-00003 – volume: 3 start-page: e000923 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib22 article-title: Body mass index, sex, and cardiovascular disease risk factors among hispanic/latino adults: hispanic community health study/study of latinos publication-title: J Am Heart Assoc doi: 10.1161/JAHA.114.000923 – volume: 1 start-page: 141 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib62 article-title: Progressing from risk factors to omics publication-title: . Circ Cardiovasc Genet doi: 10.1161/CIRCGENETICS.108.815605 – volume: 358 start-page: 2117 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib83 article-title: Cardiac troponin and outcome in acute heart failure publication-title: N Engl J Med doi: 10.1056/NEJMoa0706824 – volume: 51 start-page: 1857 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib78 article-title: Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (leicester acute myocardial infarction peptide) study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.01.041 – volume: 17 start-page: 472 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib92 article-title: Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase associated lipocalin levels than myocardial dysfunction in systolic heart failure publication-title: J Card Fail doi: 10.1016/j.cardfail.2011.02.003 – volume: 6 start-page: 91 year: 2013 ident: 10.1016/j.tcm.2016.07.005_bib133 article-title: Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA) publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.112.972653 – volume: 43 start-page: 60 year: 2010 ident: 10.1016/j.tcm.2016.07.005_bib95 article-title: Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction publication-title: Ann Med doi: 10.3109/07853890.2010.538080 – volume: 115 start-page: 2103 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib85 article-title: C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: leicester acute myocardial infarction peptide (LAMP) study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.685503 – volume: 19 start-page: 4578 year: 2013 ident: 10.1016/j.tcm.2016.07.005_bib13 article-title: Trial designs for personalizing cancer care: a systematic review and classification publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-3722 – volume: 111 start-page: 11151 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib124 article-title: Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1401724111 – volume: 355 start-page: 2631 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib31 article-title: Multiple biomarkers for the prediction of first major cardiovascular events and death publication-title: N Engl J Med doi: 10.1056/NEJMoa055373 – ident: 10.1016/j.tcm.2016.07.005_bib9 – volume: 220 start-page: 587 year: 2012 ident: 10.1016/j.tcm.2016.07.005_bib130 article-title: Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the heart and soul study publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.11.038 – volume: 106 start-page: 1442 year: 2002 ident: 10.1016/j.tcm.2016.07.005_bib132 article-title: Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance publication-title: Circulation doi: 10.1161/01.CIR.0000033117.39335.DF – volume: 456 start-page: 980 year: 2008 ident: 10.1016/j.tcm.2016.07.005_bib116 article-title: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts publication-title: Nature doi: 10.1038/nature07511 – volume: 55 start-page: 5 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib18 article-title: Evaluation of high-sensitivity assays for cardiac troponin publication-title: Clin Chem doi: 10.1373/clinchem.2008.117218 – volume: 44 start-page: 1970 year: 2004 ident: 10.1016/j.tcm.2016.07.005_bib128 article-title: Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2004.06.076 – volume: 20 start-page: 922 year: 2013 ident: 10.1016/j.tcm.2016.07.005_bib129 article-title: High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention. publication-title: Eur J Prev Cardiol doi: 10.1177/2047487313487083 – volume: 123 start-page: 551 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib8 article-title: Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.912568 – volume: 98 start-page: 309 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib60 article-title: Proteomics of the heart: unraveling disease publication-title: Circ Res doi: 10.1161/01.RES.0000201280.20709.26 – volume: 271 start-page: 436 year: 2012 ident: 10.1016/j.tcm.2016.07.005_bib91 article-title: The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA publication-title: J Intern Med doi: 10.1111/j.1365-2796.2011.02503.x – volume: 286 start-page: 180 year: 2001 ident: 10.1016/j.tcm.2016.07.005_bib23 article-title: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation publication-title: J Am Med Assoc doi: 10.1001/jama.286.2.180 – volume: 58 start-page: 1890 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib69 article-title: Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.07.032 – volume: 329 start-page: 168 year: 2004 ident: 10.1016/j.tcm.2016.07.005_bib15 article-title: Diagnostic tests 4: likelihood ratios publication-title: Br Med J doi: 10.1136/bmj.329.7458.168 – volume: 360 start-page: 1699 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib53 article-title: Genomewide association studies GÇö illuminating biologic pathways publication-title: N Engl J Med doi: 10.1056/NEJMp0808934 – volume: 102 start-page: 3046 year: 2000 ident: 10.1016/j.tcm.2016.07.005_bib48 article-title: Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays publication-title: Circulation doi: 10.1161/01.CIR.102.25.3046 – volume: 362 start-page: 1890 year: 2010 ident: 10.1016/j.tcm.2016.07.005_bib51 article-title: Gene-expression profiling for rejection surveillance after cardiac transplantation publication-title: N Engl J Med doi: 10.1056/NEJMoa0912965 – volume: 123 start-page: 2749 year: 2011 ident: 10.1016/j.tcm.2016.07.005_bib2 article-title: Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0b013e31821c7c64 – volume: 367 start-page: 1310 year: 2012 ident: 10.1016/j.tcm.2016.07.005_bib30 article-title: C-reactive protein, fibrinogen, and cardiovascular disease prediction publication-title: N Engl J Med doi: 10.1056/NEJMoa1107477 – volume: 125 start-page: 280 year: 2012 ident: 10.1016/j.tcm.2016.07.005_bib82 article-title: Serial measurement of cardiac troponin t using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.044149 – volume: 286 start-page: 180 year: 2001 ident: 10.1016/j.tcm.2016.07.005_bib24 article-title: Validation of the framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation publication-title: J Am Med Assoc doi: 10.1001/jama.286.2.180 – volume: 112 start-page: 1735 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib21 article-title: Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults publication-title: Br J Nutr doi: 10.1017/S0007114514002657 – volume: 114 start-page: 1569 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib127 article-title: Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure publication-title: Circ Res doi: 10.1161/CIRCRESAHA.114.303915 – volume: 108 start-page: 833 year: 2003 ident: 10.1016/j.tcm.2016.07.005_bib81 article-title: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure publication-title: Circulation doi: 10.1161/01.CIR.0000084543.79097.34 – volume: 22 start-page: 1096 year: 2015 ident: 10.1016/j.tcm.2016.07.005_bib93 article-title: Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand? publication-title: Eur J Prev Cardiol doi: 10.1177/2047487314552797 – ident: 10.1016/j.tcm.2016.07.005_bib1 – volume: 7 start-page: 203 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib119 article-title: MicroRNAs in heart failure: is the picture becoming less miRky? publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.113.000266 – volume: 119 start-page: 2408 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib7 article-title: Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192278 – volume: 268 start-page: 10425 year: 1993 ident: 10.1016/j.tcm.2016.07.005_bib89 article-title: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)82217-7 – volume: 50 start-page: 607 year: 2007 ident: 10.1016/j.tcm.2016.07.005_bib103 article-title: Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (pro-brain natriuretic peptide investigation of dyspnea in the emergency department) Study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.05.014 – volume: 69 start-page: 89 year: 2001 ident: 10.1016/j.tcm.2016.07.005_bib6 article-title: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework publication-title: Clin Pharmacol Ther doi: 10.1067/mcp.2001.113989 – volume: 10 start-page: 31 year: 2002 ident: 10.1016/j.tcm.2016.07.005_bib50 article-title: Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00122.2001 – volume: 360 start-page: 1759 year: 2009 ident: 10.1016/j.tcm.2016.07.005_bib56 article-title: Genomewide association studies and human disease publication-title: N Engl J Med doi: 10.1056/NEJMra0808700 – volume: 355 start-page: 2615 year: 2006 ident: 10.1016/j.tcm.2016.07.005_bib29 article-title: The limitations of risk factors as prognostic tools publication-title: N Engl J Med doi: 10.1056/NEJMp068249 – volume: 4 start-page: e004188 year: 2014 ident: 10.1016/j.tcm.2016.07.005_bib12 article-title: Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers publication-title: BMJ Open doi: 10.1136/bmjopen-2013-004188 – volume: 34 start-page: 187 year: 1972 ident: 10.1016/j.tcm.2016.07.005_bib33 article-title: Regression models and life tables. publication-title: J R Stat Soc doi: 10.1111/j.2517-6161.1972.tb00899.x – reference: 27666742 - Trends Cardiovasc Med. 2017 Feb;27(2):134-135. doi: 10.1016/j.tcm.2016.08.004. |
| SSID | ssj0006461 |
| Score | 2.5611887 |
| SecondaryResourceType | review_article |
| Snippet | Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the... Abstract Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 123 |
| SubjectTerms | Biomarkers Biomarkers - blood Cardiovascular Cardiovascular disease Cholesterol Clinical outcomes Clinical trials Data Interpretation, Statistical Genetic Markers Heart failure Heart Failure - blood Heart Failure - diagnosis Heart Failure - genetics Heart Failure - physiopathology Humans Medicine MicroRNAs Myocardium - metabolism Myocardium - pathology Peptides Predictive Value of Tests Prognosis Reproducibility of Results Severity of Illness Index Studies |
| Title | Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1050173816301050 https://www.clinicalkey.es/playcontent/1-s2.0-S1050173816301050 https://dx.doi.org/10.1016/j.tcm.2016.07.005 https://www.ncbi.nlm.nih.gov/pubmed/27576060 https://www.proquest.com/docview/1861147965 https://www.proquest.com/docview/1859739758 https://www.proquest.com/docview/1868338004 https://pubmed.ncbi.nlm.nih.gov/PMC5253084 |
| Volume | 27 |
| WOSCitedRecordID | wos000393935500007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection - Elsevier customDbUrl: eissn: 1873-2615 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006461 issn: 1050-1738 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfYhhAviG8KYyrSnpBaOYljO4-jGwLEpkkM1DfLdhytFU2rJJv253OOnTTNoHxIvESV46uVu_P5fvb5DqFDo5WOFMxvriIKAAXsYAIAbkQpSblmKeWmTpn_mZ2d8ek0OffVNsu6nADLc35zk6z-q6ihDYRtr87-hbjbP4UG-A1ChyeIHZ5_JPh3s-XCxtwUdaTrZDPe9LhzHjOvelGxerNv_9j92G5WFc7ZlNezpvmbLP1ZklxIe484LazNGHf3E0A2uI3NcCYQx3gUMJdzZWxcG2fRCLBW3LWb7k6_14-wYwQDd4PYr6eBS3Rxy1S7XYP5uNI2IUDgcqjWV7CrjpRWi1pMIQNchF3lgV5-7PPTSRzGEeZkB-1BvwRs297Rx5Ppp3ZFpsTlzW2-rDndruP8euPb7NB-sF-5KrehSD-ituOiXDxEDzy2GB45nXiE7pj8Mbp36sX4BB2uVWM4y4ebqjH0qvEUfX1_cjH5MPJVMkYaoGYF8ChSxG5KJZyQUPHIpGkSMpNRwlMAqDRRqYqkNACsaSgzZSTPtMJxakIigfoZ2s2XuXmBhlJnUiY4zpQGRxNrqaKMMqUS8IJhKscDhBuGCO1TyNtKJt9FEys4F8BOYdkpsA1sAJK3LcnK5U_Z1jlsuCyai8GwlAlQmW1E7GdEpvRzshSBKEOBxRcrfyt-gCC2LiweINJSen_T-ZG_G3C_UQCxHoPTICAssUx6074GU23P32Rulle2D6B38P9jvq0P5VEEKI4M0HOnUy3fGr2EL97QtraDTRW_-SafXdYp4_0MefnPlK_Q_bWx2Ee7VXFlXqO7-rqalcUB2mFTfuCn3Q_u0OGf |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biomarkers+in+Cardiovascular+Disease&rft.jtitle=Trends+in+cardiovascular+medicine&rft.au=Dhingra%2C+Ravi&rft.au=Vasan%2C+Ramachandran+S.&rft.date=2017-02-01&rft.issn=1050-1738&rft.eissn=1873-2615&rft.volume=27&rft.issue=2&rft.spage=123&rft.epage=133&rft_id=info:doi/10.1016%2Fj.tcm.2016.07.005&rft_id=info%3Apmid%2F27576060&rft.externalDocID=PMC5253084 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10501738%2FS1050173816X00096%2Fcov150h.gif |